Storia in 17 fonti

'Transformative' pancreatic cancer drug doubles survival time

People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions

Raccontata da

cnn.com+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

newscientist.comStai leggendo18 h fa

'Transformative' pancreatic cancer drug doubles survival time

Daraxonrasib doubled survival to 13.2 months (vs 6.7) in 500 treatment-resistant pancreatic cancer patients, with 90% lower side-effect dropout rates. First KRAS breakthrough in two decades; signals precision medicine momentum for oncology data stack and biotech investment decisions.

originale

Timeline cronologica

sabato 30 maggio 2026·pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
domenica 31 maggio 2026·healio.com
Daraxonrasib offers ‘transformational’ benefit in metastatic pancreatic cancer
CHICAGO — The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based on the buzz it created among ASCO Annual Meeting…

'Transformative' pancreatic cancer drug doubles survival time

Confronto fonti

'Transformative' pancreatic cancer drug doubles survival time

Timeline cronologica

Pancreatic cancer is deadly and difficult to treat. A new pill could change that

Daraxonrasib offers ‘transformational’ benefit in metastatic pancreatic cancer

'Transformative' pancreatic cancer drug doubles survival time

Confronto fonti

'Transformative' pancreatic cancer drug doubles survival time

Timeline cronologica

Pancreatic cancer is deadly and difficult to treat. A new pill could change that

Daraxonrasib offers ‘transformational’ benefit in metastatic pancreatic cancer

This drug can double survival time for pancreatic cancer patients

Daily pill almost doubles survival time for pancreatic cancer patients in new trial

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually…

Why this new pill for a deadly cancer has doctors excited

‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer

'Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

Daily pill almost doubles survival time for pancreatic cancer patients in new trial

Daily pill can double survival time for world’s deadliest cancer, trial shows

New drug gives extra months of life to pancreatic cancer patients

Experimental pill promises new hope for deadly pancreatic cancer

Cancer breakthrough as new 'game-changing' pill could double survival time

Pancreatic cancer breakthrough as pill almost doubles survival time for patients

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

Experimental pill promises new hope for deadly pancreatic cancer | CNN

Experimental pill offers breakthrough hope in pancreatic cancer fight

Why this new pill for a deadly cancer has doctors excited

Cancro al pancreas, un nuovo farmaco raddoppia il periodo di sopravvivenza: lo studio - Il Quotidiano del Sud

Experimental drug shows promise against deadly pancreatic cancer

Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments

Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers